Kevin Rakin

Track

Insider profile

Currently holds a position at Oramed Pharmaceuticals Inc

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 86% 68% 82%
Transactions
5 60% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, Independent Director Oramed Pharmaceuticals Inc Aug. 1, 2016 -
Independent Director Ocugen Inc Oct. 1, 2012 - June 20, 2019
Kevin Rakin's trades of Nyxoah SA's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
BE Nyxoah SA (NYXH)
Transaction date
Purchase
Price
135.83
Quantity 88,939
Value US$2,747,452
US Elutia Inc (ELUT)
Transaction date
Purchase
Price
336.47
Quantity 89,721 -21.8%
Value US$747,669
US Elutia Inc (ELUT)
Transaction date
Purchase
Price
147.96
Quantity 27,663 -7.7%
Value US$4,945,428
Transaction date
Sale
Price
2.15
Quantity 89,000 -4.7%
Value US$191,234
BE Nyxoah SA (NYXH)
Transaction date
Purchase
Price
0.17
Quantity 5,560
Value €955
Transaction date
Sale
Price
9.41
Quantity 10,000 -17.6%
Value US$94,096
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-19 2026-06-09
BE Nyxoah SA (NYXH)
B Purchase
88,939
135.83
US$2,747,452 		88,939 135.83 US$2,747,452
2026-02-02 2026-01-30
US Elutia Inc (ELUT)
B Purchase
89,721 -21.8%
336.47
US$747,669 		89,721 -21.8% 336.47 US$747,669
2025-12-19 2025-12-17
US Elutia Inc (ELUT)
B Purchase
27,663 -7.7%
147.96
US$4,945,428 		27,663 -7.7% 147.96 US$4,945,428
2022-12-16 2022-12-15
S Sale
89,000 -4.7%
2.15
US$191,234 		89,000 -4.7% 2.15 US$191,234
2022-08-09 2022-06-08
BE Nyxoah SA (NYXH)
B Purchase
5,560
0.17
€955 		5,560 0.17 €955
2022-03-22 2022-03-21
S Sale
10,000 -17.6%
9.41
US$94,096 		10,000 -17.6% 9.41 US$94,096